FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
LIFEARC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079412583Class
9, 16, 35, 36, 41, 42, 44, 45
Filing
79412583
Registration
8226555
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/28/2026
Trademark type
Combined
Nice classes
9, 16, 35, 36, 41, 42, 44, 45
Filing date
04/29/2024
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
GB
Examiner
GEARHART, DAVID JAMES
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
LIFEARC
Representatives
David M. Abrahams Webster, Chamberlain & Bean, LLP
Technical classification
Nice Classes
Class 9Class 16Class 35Class 36Class 41Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable electronic educational and professional publicationsnewslettersfact sheetsbrochures about a biomedical and scientific research facility; downloadable electronic educational and professional podcasts and webcasts featuring information about biomedical and scientific research on human health and human diseases.
Class 16
Printed educational and professional publicationsprinted newslettersfact sheetsbrochures about biomedical and scientific research and information about biomedical and scientific research on human health and human diseases.
Class 35
Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universitieshospitalsresearch foundations and businesses; business consultation services in the nature of providing assistance in the field of commercialisation of products and services by identifying routes to market for research; business assistancemanagement and administration services; advisoryconsultancy and information services relating to all the aforesaid; compilation of scientificmedical and clinical information into computer databases; collection of business data in connection with clinical trials for business purposes.
Class 36
Charitable fundraising; charitable fundraising collections; organisation of collections in the nature of charitable fundraising; charitable servicesprovision of funding for researcheducationprevention and treatment of illnesses and human diseases; financial grant servicesproviding grants for researcheducationpreventiontreatment of illnesses and human diseases; provision of funding for charities in the nature of philanthropic services concerning monetary donations; charitable foundation servicesprovision of funding for medical trials; charitable foundation servicesprovision of funding for educational and research posts; intellectual property venture fund development and formation services for others enabling inventors of new technology to secure appropriate funding for continued technological development; technology transfer servicesfinancial asset management in the nature of managing revenue from partnered or developed intellectual property; advisoryconsultancy and information services relating to all the aforesaid.
Class 41
Providing educationaltraining and mentoring services concerning the causespreventiondetectiondiagnosistreatment of diseases through educational conferencesseminars and written materials disseminated in connection therewith; providing educational conferencesseminarswebinars in the field of the causespreventiondetectiondiagnosistreatment of diseases and dissemination of printed educational materials therewith; providing educational conferencesseminarswebinars in the field of the causespreventiondetectiondiagnosistreatment of diseases and dissemination of online educational materials therewith; publishing including online publishing of journal articlespress releaseswhite papers and books; advisoryconsultancy and information services relating to all the aforesaid.
Class 42
Scientificmedical and clinical research services; scientific research and scientific analysis in the field of biotechnology; scientific research and scientific analysis in the field of biochemistry; scientific research and scientific analysis in the field of biology; conducting clinical trials for others; data mining; data security consultancy services; data encryption services; database design and development; maintenance of computer software for databases; mathematical modelling services; scientific and technological servicesscientific research and analysis in the field of bioinformatics; drug discovery services; laboratory research in the field of medicine; computer programming and software design services; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research servicescalibrationanalysis and reporting of data in connection with clinical trials; conducting clinical trials for others for diagnostic tests and for pharmaceutical preparations; providing temporary use of non-downloadable web-based computer software for data integrationexchangeanalysis; providing biomedical and scientific information in the field of human health and diseases; technology transfer servicesnamely new product design and development services; scientific research and development services; antibody humanization servicesnamely antibody engineering in the nature of antibody research and development services; biopharmaceutical product development; biologic assay product development; medical researchpreclinical research; clinical research in the in the fields of genetic disordersinfectious diseases and rare diseases; consulting services for others in the designplanningimplementation of project management of clinical trials; testing and inspection of pharmaceuticals in the nature of pharmacovigilancemonitoring the effects of medical drugs after they have been licensed for use; advisoryconsultancy and information services relating to all the aforesaid.
Class 44
Pharmaceutical treatment diagnostics in the nature of medical and pharmaceutical consultation; medical services; advice on medical information relating to alleviationdiagnosisprevention and treatment of illnesses and human diseases; advisoryconsultancy and information services relating to all the aforesaid.
Class 45
Legal services; licensing of technologypatent licensing; licensing and intellectual property services in relation to technology transfer servicesconsulting in the field of intellectual property; advisoryconsultancy and information services relating to all the aforesaid.
Publications
History of USPTO decisions and trademark events.
31 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/18/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/18/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/13/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/13/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/13/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/13/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/12/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/12/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/12/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/12/2026
RFNT
REFUSAL PROCESSED BY IB
10/18/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/26/2025
RFRR
REFUSAL PROCESSED BY MPU
09/26/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/15/2025
CNRT
NON-FINAL ACTION WRITTEN
08/14/2025
DOCK
ASSIGNED TO EXAMINER
08/13/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/12/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/19/2024
Continuous trademark protection
Get notified about every new filing that threatens LIFEARC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.